Adaptive Randomization of Neratinib in Early Breast Cancer
N Engl J Med
.
2016 Oct 20;375(16):1591-2.
doi: 10.1056/NEJMc1609993.
Authors
Marc Buyse
1
,
Everardo D Saad
1
,
Tomasz Burzykowski
1
Affiliation
1
International Drug Development Institute, Louvain-la-Neuve, Belgium marc.buyse@iddi.com.
PMID:
27797315
DOI:
10.1056/NEJMc1609993
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms / drug therapy*
Humans
Quinolines / therapeutic use
Random Allocation*
Receptor, ErbB-2
Substances
Quinolines
Receptor, ErbB-2